Premarketing Clinical Trial Safety
The Premarketing Clinical Trial Safety module provides a framework and details around drug safety requirements for clinical trials for drugs in humans. This module provides information about safety and ethical safeguards in place to protect human subjects in clinical trials. The typical clinical process of pre-marketing development consists of two successive periods that complete each other. The first one or learning phase that investigates, and the second one or confirmatory phase that validates. The learning phase corresponds to the phases traditionally labelled I and II and the confirmatory phase covers the traditional late phase II and phase III. Premarketing studies will provide the details on individual case reporting and aggregate reporting requirements. Finally, the module will discuss risk assessment and the premarketing review of safety data in an application. Pharmacoepidemiology Researches invites an article to publish in the Journal of Pharmacovigilance and Pharmacoepidemiology. Pharmacovigilance and Pharmacoepidemiology is a scholarly journal maintaining high standards of Pharmacoepidemiology Researches.
PDF
